Skip to content

Stock market index DAX responds to United States inflation data, with attention on shares of companies like Bayer

US Inflation Stands at 2.5%, DAX Slightly Upswing. Commerzbank Shares Surge 18% Amid Takeover Speculations, Bayer Dips Due to Legal Battles over Glyphosate

US inflation data impact on DAX index, with Bayer Corporation stocks under scrutiny
US inflation data impact on DAX index, with Bayer Corporation stocks under scrutiny

Stock market index DAX responds to United States inflation data, with attention on shares of companies like Bayer

The US Federal Reserve's monetary policy is under scrutiny as the high core inflation rate may curb anticipations of interest rate cuts. According to Helaba, the most probable scenario is a modest interest rate hike by the US Federal Reserve.

The US inflation rate for August dropped to 2.5%, the lowest since February 2021, offering a glimmer of hope. However, the core inflation rate, which excludes energy and food prices, showed an unexpected increase compared to July, keeping the rate above three percent.

The stock market in Europe, as represented by the DAX and the Euro Stoxx 50, is experiencing a positive trend. The DAX is currently up 0.5 percent at 18,365 points, while the Euro Stoxx 50 is up 0.6 percent at 4,777 points. Notable gains have been made by Siemens Energy shares, which have risen over 2.8 percent, and Commerzbank shares, which have surged 18 percent, due to speculation about a potential takeover by Unicredit.

In corporate news, Goldman Sachs has issued a warning about potential pressure on corporate profits and stocks. BMW shares have gained almost three percent after a sharp decline yesterday due to issues with supplied brake systems.

Bayer, the German pharmaceutical and life sciences company, faces ongoing legal risks from glyphosate lawsuits in the US. However, the company received relief as the US government decided against re-evaluating glyphosate's safety, supporting Bayer's position. Despite this, Bayer's share in the DAX is experiencing a loss of over two percent, reflecting the ongoing controversy and legal threats that impact the company's stock.

Meanwhile, Continental shares have not recovered and are down two percent today. A report by the "Rheinische Post" did not provide new insights regarding Bayer's appeal to the highest US court.

These developments underscore the dynamic and interconnected nature of global financial markets and corporate landscapes. As always, investors are advised to stay informed and make decisions based on thorough analysis and strategic planning.

Read also: